Charles & Colvard Q2 EPS $(0.09) Down From $(0.03) YoY, Sales $7.91M Down From $10.37M YoY
Portfolio Pulse from mahesh@benzinga.com
Charles & Colvard (CTHR) reported a significant decrease in both earnings per share and sales for Q2, with EPS down 200% to $(0.09) from $(0.03) YoY, and sales down 23.73% to $7.91M from $10.37M YoY.
February 13, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Charles & Colvard's Q2 earnings show a significant downturn, with a 200% decrease in EPS and a 23.73% drop in sales YoY.
The reported decrease in both EPS and sales for Charles & Colvard is significant and likely to negatively impact investor sentiment in the short term. A 200% decrease in EPS and a 23.73% drop in sales YoY are critical indicators of the company's current financial health and operational challenges, which could lead to a decrease in stock price as investors react to the negative earnings report.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100